These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8449096)

  • 1. Immunologic therapy for ARDS, septic shock, and multiple-organ failure.
    St John RC; Dorinsky PM
    Chest; 1993 Mar; 103(3):932-43. PubMed ID: 8449096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory therapies: application of molecular biology techniques in intensive care medicine.
    Liu M; Slutsky AS
    Intensive Care Med; 1997 Jul; 23(7):718-31. PubMed ID: 9290984
    [No Abstract]   [Full Text] [Related]  

  • 3. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators.
    Welbourn CR; Young Y
    Br J Surg; 1992 Oct; 79(10):998-1003. PubMed ID: 1422741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host responses in mediating sepsis and adult respiratory distress syndrome.
    Strieter RM; Lynch JP; Basha MA; Standiford TJ; Kasahara K; Kunkel SL
    Semin Respir Infect; 1990 Sep; 5(3):233-47. PubMed ID: 2123991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for sepsis.
    Mercier JC
    Crit Care Med; 1993 Sep; 21(9 Suppl):S310-4. PubMed ID: 8365201
    [No Abstract]   [Full Text] [Related]  

  • 6. Current understanding of the pathogenesis of gram-negative shock.
    Waage A; Brandtzaeg P; Espevik T; Halstensen A
    Infect Dis Clin North Am; 1991 Dec; 5(4):781-91. PubMed ID: 1783767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in immunotherapy of sepsis.
    Klein DM; Witek-Janusek L
    Dimens Crit Care Nurs; 1992; 11(2):75-89. PubMed ID: 1576902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemistry, molecular mechanism of action and biological effects of endotoxin].
    Burgmann H; Breyer S
    Wien Med Wochenschr; 1995; 145(9):211-7. PubMed ID: 7543712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septic shock, multiple organ failure, and acute respiratory distress syndrome.
    Sharma S; Kumar A
    Curr Opin Pulm Med; 2003 May; 9(3):199-209. PubMed ID: 12682565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system organ failure and the sepsis syndrome.
    Bone RC
    Hosp Pract (Off Ed); 1991 Nov; 26(11):101-9;discussion 109-26. PubMed ID: 1939410
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathogenesis of septic shock.
    Sriskandan S; Cohen J
    J Infect; 1995 May; 30(3):201-6. PubMed ID: 7673742
    [No Abstract]   [Full Text] [Related]  

  • 13. The etiology and treatment of traumatic and septic shock.
    Hardaway RM
    Compr Ther; 1999; 25(6-7):330-4. PubMed ID: 10470517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric septic shock and multiple organ failure.
    Carcillo JA
    Crit Care Clin; 2003 Jul; 19(3):413-40, viii. PubMed ID: 12848313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonococcal septic shock, acute respiratory distress syndrome, and multisystem organ failure: a case report.
    Landy J; Djogovic D; Sligl W
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e239-41. PubMed ID: 20045369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of cell adhesion molecules and proinflammatory mediators in the pathogenesis of endotoxin adult respiratory distress syndrome].
    Lazarov S; Balutsov M; Ianev E
    Vutr Boles; 2000; 32(4):18-24. PubMed ID: 11688326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary complications within the scope of multiple organ failure].
    Forst H; Briegel J; Unertl K; Peter K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():823-7. PubMed ID: 2577646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of hemofiltration in the treatment of patients with septic shock and multiple organ dysfunction syndrome.
    Grootendorst AF
    Adv Ren Replace Ther; 1994 Jul; 1(2):176-84. PubMed ID: 7614318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple organ failure. Pathophysiology and potential future therapy.
    Deitch EA
    Ann Surg; 1992 Aug; 216(2):117-34. PubMed ID: 1503516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report.
    Bruenger F; Kizner L; Weile J; Morshuis M; Gummert JF
    Int J Artif Organs; 2015 Feb; 38(2):113-6. PubMed ID: 25656010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.